EFT Biotech Holdings, Inc., Tops $100 Million in Gross Sales

EFT BioTech Holdings, Inc. (OTC: EFTB) a business to consumer, on line marketing Company providing "Made in the USA" health, beauty, nutriceutical products along with other goods and services under the EFT brand to its affiliate member network, boasting almost one million members strong, reports surpassing $100 million in gross sales since its public listing in November 2007.

Jack Qin, President and CEO stated, "We are just beginning to implement many of our new expansion plans into new target markets as shown by our recent opening of a member educational office in Seoul, South Korea. More importantly, during the month of August 2009, we have already surpassed $112 million in gross sales since our public listing in November 2007."

George Curry, Vice President, of EFT also commented, "We belive that the Company is now on track for very strong growth over the next few quarters. Typically, the most recent two closing quarters are our slowest period of the year. Assuming history holds true, combined with recent office expansion to attract new affiliate members in different territories, we believe we are positioned for a stellar second half of our fiscal year ending March 2010."

About EFT BioTech Holdings. Inc.

EFT BioTech Holdings, Inc. is a Nevada Corporation, which conducts its business through wholly owned subsidiaries and various vested interests. EFT is a worldwide business to consumer marketing company utilizing a large individual membership base to sell proprietary personal products and other unique services. Headquartered in Southern California the Company services members primarily in Asia, Eastern Europe and Latin America. The Company anticipates the advent of new products and services further fueling future growth.

Safe Harbor for Forward-Looking Statements

This release may contain forward-looking statements. Investors are encouraged to review regulatory filings prior to investment consideration. Past performance is no guarantee of future success. The Company is in a rapid growth sector that may or may not continue to grow in the future and therefore poses risks that may be different than other investments. Management regularly provide news and additional information believed to be true and accurate at the time of dissemination but has no requirement to modify, comment or change in the future should circumstance change or information prove to be inaccurate for any reason. Additionally, the Company makes every effort to comply wit all applicable law and regulatory concerns but cannot assure investors of any material changes outside of their best efforts.

For Investors and Media Information Please Contact:

Edward Carter 702-561-1790

To Register for Instant News Notification by email, please go to EFTB.Info

Jack Jie Qin, President, CEO

EFT Biotech Holdings, Inc.

929 Radecki Ct

City of Industry, CA 91789

USA

Phone: 626-581-0388

Fax: 720-226-0664

Note: The following news is from EFT Biotech Holdings, Inc., and World Stock Wire, Inc. is not liable for the contents of this news.

Related terms: asia, biotechnology, business, california, ceo, connecticut, consumer, email, europe, health, investment, law, marketing, media, nevada, note, otc, president, products, south korea, track